Back
Insulet Corporation

Insulet Corporation

PODD

Loading Stocks

$304.00

$0.92 (0.30%)

1D

1W

3M

1Y

5Y

ALL

Overview

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.

Open

$300.05

Prior close

$303.62

Today's high

$308.79

Today's low

$299.61

52 Week high

$329.33

52 Week low

$173.00
News
Here's Why You Should Retain PODD Stock in Your Portfolio Now
Newsfeed image icon
3 Medical Technology Stocks Outperforming in 2025
Newsfeed image icon
Here's Why Insulet (PODD) is a Strong Growth Stock
Newsfeed image icon
S&P 500 Wraps Up Best May Since 1990: 5 Top Stocks in the ETF
Newsfeed image icon
Insulet Gains 78.5% in a Year: What's Driving the Stock?
Newsfeed image icon
View disclosures

Start Your Investing Journey At MoneyLion

Access fully managed portfolios to help you invest towards your future, without the heavy lifting.

Market Data

Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.